Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy

Summary

The primary objective of this randomized trial is to measure the impact of converting patients on statin therapy from fenofibrate 160mg to 54mg per day compared to patients who continue fenofibrate 160mg per day for triglycerides.

Timeline

Start

2010-10

Primary completion

2013-01

Completion

2013-01

Drugs

Indications